Utah Medical Products (UTMD) Competitors $56.43 -0.78 (-1.36%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$56.30 -0.13 (-0.23%) As of 07/11/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock UTMD vs. CERS, OSUR, ANIK, WST, COO, ALGN, MMSI, HAE, ICUI, and XRAYShould you be buying Utah Medical Products stock or one of its competitors? The main competitors of Utah Medical Products include Cerus (CERS), OraSure Technologies (OSUR), Anika Therapeutics (ANIK), West Pharmaceutical Services (WST), Cooper Companies (COO), Align Technology (ALGN), Merit Medical Systems (MMSI), Haemonetics (HAE), ICU Medical (ICUI), and DENTSPLY SIRONA (XRAY). These companies are all part of the "health care supplies" industry. Utah Medical Products vs. Its Competitors Cerus OraSure Technologies Anika Therapeutics West Pharmaceutical Services Cooper Companies Align Technology Merit Medical Systems Haemonetics ICU Medical DENTSPLY SIRONA Cerus (NASDAQ:CERS) and Utah Medical Products (NASDAQ:UTMD) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, earnings, profitability, media sentiment, valuation and risk. Do analysts prefer CERS or UTMD? Cerus presently has a consensus target price of $3.50, indicating a potential upside of 141.38%. Given Cerus' stronger consensus rating and higher probable upside, research analysts plainly believe Cerus is more favorable than Utah Medical Products.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cerus 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Utah Medical Products 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has more volatility & risk, CERS or UTMD? Cerus has a beta of 1.56, indicating that its share price is 56% more volatile than the S&P 500. Comparatively, Utah Medical Products has a beta of 0.28, indicating that its share price is 72% less volatile than the S&P 500. Which has stronger valuation & earnings, CERS or UTMD? Utah Medical Products has lower revenue, but higher earnings than Cerus. Cerus is trading at a lower price-to-earnings ratio than Utah Medical Products, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCerus$180.27M1.54-$20.92M-$0.10-14.50Utah Medical Products$40.90M4.48$13.87M$3.7814.93 Do insiders & institutionals have more ownership in CERS or UTMD? 78.4% of Cerus shares are held by institutional investors. Comparatively, 69.6% of Utah Medical Products shares are held by institutional investors. 5.6% of Cerus shares are held by insiders. Comparatively, 7.4% of Utah Medical Products shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Does the media refer more to CERS or UTMD? In the previous week, Utah Medical Products had 1 more articles in the media than Cerus. MarketBeat recorded 2 mentions for Utah Medical Products and 1 mentions for Cerus. Cerus' average media sentiment score of 1.24 beat Utah Medical Products' score of 0.94 indicating that Cerus is being referred to more favorably in the media. Company Overall Sentiment Cerus Positive Utah Medical Products Positive Is CERS or UTMD more profitable? Utah Medical Products has a net margin of 33.00% compared to Cerus' net margin of -10.23%. Utah Medical Products' return on equity of 10.74% beat Cerus' return on equity.Company Net Margins Return on Equity Return on Assets Cerus-10.23% -34.81% -9.68% Utah Medical Products 33.00%10.74%10.27% SummaryUtah Medical Products beats Cerus on 9 of the 16 factors compared between the two stocks. Get Utah Medical Products News Delivered to You Automatically Sign up to receive the latest news and ratings for UTMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding UTMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart UTMD vs. The Competition Export to ExcelMetricUtah Medical ProductsMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$185.83M$10.60B$5.60B$9.11BDividend Yield2.13%2.07%5.24%4.02%P/E Ratio14.9316.2727.9620.25Price / Sales4.4830.15430.8999.65Price / Cash11.6022.9637.4658.16Price / Book1.633.668.045.49Net Income$13.87M$235.43M$3.18B$250.27M7 Day Performance-3.22%1.27%3.63%4.75%1 Month Performance-1.62%2.95%4.04%7.64%1 Year Performance-17.78%-15.74%29.55%16.34% Utah Medical Products Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)UTMDUtah Medical Products1.9922 of 5 stars$56.43-1.4%N/A-18.6%$185.83M$40.90M14.93180Positive NewsCERSCerus2.5372 of 5 stars$1.41-0.7%$3.50+148.2%-31.3%$271.45M$180.27M-14.10290Positive NewsOSUROraSure Technologies2.5536 of 5 stars$3.00-0.3%$3.00-27.8%$225.15M$185.83M-7.14840News CoverageANIKAnika Therapeutics4.3186 of 5 stars$10.58-1.5%$20.00+89.0%-59.0%$154.03M$119.91M-2.73300Positive NewsWSTWest Pharmaceutical Services4.8049 of 5 stars$218.800.0%$320.00+46.3%-31.9%$15.72B$2.89B34.3510,700COOCooper Companies3.1185 of 5 stars$71.16+0.0%$99.70+40.1%-15.6%$14.23B$3.90B34.5414,000Analyst DowngradeALGNAlign Technology4.6292 of 5 stars$189.33+0.4%$241.25+27.4%-21.1%$13.66B$4.00B34.4920,945Positive NewsAnalyst ForecastMMSIMerit Medical Systems4.3208 of 5 stars$93.480.0%$109.11+16.7%+7.1%$5.53B$1.36B45.827,400Positive NewsAnalyst ForecastHAEHaemonetics4.9159 of 5 stars$74.77+1.3%$96.80+29.5%-15.6%$3.55B$1.36B22.593,023News CoverageAnalyst UpgradeAnalyst RevisionICUIICU Medical4.4122 of 5 stars$132.15+0.3%$192.67+45.8%+3.1%$3.24B$2.38B-34.5015,000Positive NewsXRAYDENTSPLY SIRONA4.4703 of 5 stars$15.88-0.3%$20.36+28.2%-37.0%$3.17B$3.79B-3.5014,000 Related Companies and Tools Related Companies Cerus Alternatives OraSure Technologies Alternatives Anika Therapeutics Alternatives West Pharmaceutical Services Alternatives Cooper Companies Alternatives Align Technology Alternatives Merit Medical Systems Alternatives Haemonetics Alternatives ICU Medical Alternatives DENTSPLY SIRONA Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:UTMD) was last updated on 7/12/2025 by MarketBeat.com Staff From Our Partners3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Utah Medical Products, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Utah Medical Products With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free UTMD Stock Alerts